Skip to main content

Table 1 Preoperative demographic, clinical, and echocardiographic data

From: Outcome of MC3 ring annuloplasty for moderate and severe functional tricuspid regurgitation associated with rheumatic mitral valve disease

VariablesDeVega (n = 82)MC3 ring (n = 23)P value
Age (years)48 ± 11.846.2 ± 11.20.53
Female gender53 (64.6%)14 (60.9%)0.74
NYHA class (III/IV)52 (63.4%)16 (69.6%)0.58
Atrial fibrillation45 (54.9%)13 (56.6%)0.88
Mitral valve disease
 Stenosis18 (23.2%)6 (26.1%)0.68
 Insufficiency25 (30.5%)4 (17.4%)0.29
 Stenosis and insufficiency38 (46.3%)13 (56.5%)0.38
Preoperative TR grade2.55 ± 0.612.39 ± 0.650.28
SPAP (mmHg)47.87 ± 14.7052.21 ± 15.430.21
TA diameter (mm)34.62 ± 5.3334.56 ± 5.560.96
TAPSE (mm)18.23 ± 3.1117.13 ± 2.760.12
LAD (mm)42.97 ± 4.1042.13 ± 4.330.39
LVEDD (mm)42.34 ± 2.3742.08 ± 2.870.66
LVESD (mm)34.32 ± 1.7934.21 ± 1.470.78
LVEF (%)55.73 ± 8.9355.13 ± 9.450.77
  1. NYHA New York Heart Association, TR tricuspid regurgitation, SPAP systolic pulmonary artery pressure, TA tricuspid annulus, TAPSE tricuspid annular plane systolic excursion, LAD left atrial diameter, LVEDD left ventricular end-diastolic dimension, LVESD left ventricular end-systolic dimension, LVEF left ventricular ejection fraction